Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received ...

Cervical cancer screening is one of the best success stories in health care. Since the 1970s, the death rate from cervical ...

Nearly 13,400 new cases of invasive cervical cancer will be diagnosed this year and about 4,300 women will die from the ...

Mom of 3 Molly Pardue was diagnosed with cervical cancer after demanding a pap smear — and underwent chemotherapy and other ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...

Cervical cancer, which is driven by the human papillomavirus (HPV), begins in the cells of the cervix and slowly grows over ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

A study of more than 160,000 women in New Mexico published in Preventative Medicine found that between January 2015 and August 2019, only half who tested positive for cancer-causing HPV cells ...